MLchartDataset catalogue

triptorelin

Term · Oncology and biomedicine · MLC-T-ONC-017331

A synthetic decapeptide agonist analog of luteinizing hormone releasing hormone (LHRH). Possessing greater potency than endogenous LHRH, triptorelin reversibly represses gonadotropin secretion. After chronic, continuous administration, this agent effects sustained decreases in LH and FSH production and testicular and ovarian steroidogenesis. Serum testosterone concentrations may fall to levels typically observed in surgically castrated men.

Table 1. Record
IdentifierMLC-T-ONC-017331
FieldOncology and biomedicine
Synonyms6-D-tryptophan-LH-RH; 6-D-tryptophanluteinizing hormone-releasing factor; detryptoreline
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-017331",
  "term": "triptorelin",
  "field": "Oncology and biomedicine",
  "definition": "A synthetic decapeptide agonist analog of luteinizing hormone releasing hormone (LHRH). Possessing greater potency than endogenous LHRH, triptorelin reversibly represses gonadotropin secretion. After chronic, continuous administration, this agent effects sustained decreases in LH and FSH production and testicular and ovarian steroidogenesis. Serum testosterone concentrations may fall to levels typically observed in surgically castrated men.",
  "synonyms": [
    "6-D-tryptophan-LH-RH",
    "6-D-tryptophanluteinizing hormone-releasing factor",
    "detryptoreline"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/triptorelin/"
}

Record 16,736 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.